Antibiotic shows promise for treating fragile X syndrome

04/10/2013 | Disability Scoop

Children with fragile X syndrome who received minocycline had modest improvements in anxiety levels and mood-related behaviors compared with a placebo group, researchers report in the Journal of Developmental and Behavioral Pediatrics. Some patients responded better to the medication than others, and researchers are looking for predictive biomarkers.

View Full Article in:

Disability Scoop

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL